<p>A) HPV<sup>+</sup>TSCC and B) HPV<sup>−</sup>TSCC patients stratified by the number of CD8<sup>+</sup> TILs. High and low denotes CD8<sup>+</sup> TIL count above and below the median values of 33 for HPV<sup>+</sup>TSCC and 4.4 HPV<sup>−</sup>TSCC. C) HPV<sup>+</sup>TSCC and D) HPV<sup>−</sup>TSCC patients stratified by the ratio of CD8<sup>+</sup>/FoxP3<sup>+</sup> cell ratio. High and low denotes CD8<sup>+</sup>/FoxP3<sup>+</sup> cell ratio above and below 1.</p
Kaplan-Meier survival curves for (A) the progression-free survival (PFS), and (B) the overall surviv...
<p>(A) DFS stratified for HCA-2 intensity, (B) DSS stratified for HCA-2 intensity, (C) OS stratified...
<p>Kaplan-Meier survival curves comparing cumulative survival at teaching facilities (TF) and non-te...
<p>A and D: DFS (A) and OS (D) for TSCC and BOTSCC irrespective of the HPV status of the tumour. B a...
<p>A and D: DFS (A) and OS (D) for TSCC and BOTSCC irrespective of the HPV status of the tumour. B a...
<p>A and D: DFS (A) and OS (D) for TSCC and BOTSCC irrespective of the HPV status of the tumour. B a...
<p>Survival curve with Kaplan-Meier estimates of (a) overall survival and (b) disease specific survi...
<p>(<b>A</b>) Overall survival rate for 674 patients with LSCC (<b>B</b>) Progression-free survival ...
<p>Kaplan–Meier disease-free survival curve (A) and disease-specific survival curve (B) according to...
<p>Data on 5-years Overall Survival and Trend test are shown according to each staging system for HP...
<p>Kaplan-Meier survival curves of (A) progression-free survival (PFS) and (B) overall survival (OS)...
<p>Data on 5-years Overall Survival and Trend test are shown according to each staging system for HP...
<p>Kaplan-Meier curves on overall survival (A and B) and progression-free survival (C and D), as str...
<p>Survival curve of the patients in relation to HPV positivity and negativity low and high risk.</p
<p>HNSCC versus control patients (upper panel) and HNSCC patients adjusted by whether HPV infected t...
Kaplan-Meier survival curves for (A) the progression-free survival (PFS), and (B) the overall surviv...
<p>(A) DFS stratified for HCA-2 intensity, (B) DSS stratified for HCA-2 intensity, (C) OS stratified...
<p>Kaplan-Meier survival curves comparing cumulative survival at teaching facilities (TF) and non-te...
<p>A and D: DFS (A) and OS (D) for TSCC and BOTSCC irrespective of the HPV status of the tumour. B a...
<p>A and D: DFS (A) and OS (D) for TSCC and BOTSCC irrespective of the HPV status of the tumour. B a...
<p>A and D: DFS (A) and OS (D) for TSCC and BOTSCC irrespective of the HPV status of the tumour. B a...
<p>Survival curve with Kaplan-Meier estimates of (a) overall survival and (b) disease specific survi...
<p>(<b>A</b>) Overall survival rate for 674 patients with LSCC (<b>B</b>) Progression-free survival ...
<p>Kaplan–Meier disease-free survival curve (A) and disease-specific survival curve (B) according to...
<p>Data on 5-years Overall Survival and Trend test are shown according to each staging system for HP...
<p>Kaplan-Meier survival curves of (A) progression-free survival (PFS) and (B) overall survival (OS)...
<p>Data on 5-years Overall Survival and Trend test are shown according to each staging system for HP...
<p>Kaplan-Meier curves on overall survival (A and B) and progression-free survival (C and D), as str...
<p>Survival curve of the patients in relation to HPV positivity and negativity low and high risk.</p
<p>HNSCC versus control patients (upper panel) and HNSCC patients adjusted by whether HPV infected t...
Kaplan-Meier survival curves for (A) the progression-free survival (PFS), and (B) the overall surviv...
<p>(A) DFS stratified for HCA-2 intensity, (B) DSS stratified for HCA-2 intensity, (C) OS stratified...
<p>Kaplan-Meier survival curves comparing cumulative survival at teaching facilities (TF) and non-te...